0.4749
前日終値:
$0.46
開ける:
$0.46
24時間の取引高:
898.35K
Relative Volume:
0.39
時価総額:
$67.23M
収益:
-
当期純損益:
$-119.76M
株価収益率:
-0.3518
EPS:
-1.35
ネットキャッシュフロー:
$-55.17M
1週間 パフォーマンス:
+12.35%
1か月 パフォーマンス:
+38.50%
6か月 パフォーマンス:
-24.43%
1年 パフォーマンス:
-90.67%
Applied Therapeutics Inc Stock (APLT) Company Profile
名前
Applied Therapeutics Inc
セクター
電話
212-220-9226
住所
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
APLT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
APLT
Applied Therapeutics Inc
|
0.4749 | 59.84M | 0 | -119.76M | -55.17M | -1.35 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-23 | ダウングレード | William Blair | Outperform → Mkt Perform |
2024-12-02 | ダウングレード | UBS | Buy → Neutral |
2024-11-29 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
2024-07-31 | 開始されました | William Blair | Outperform |
2024-03-26 | 開始されました | RBC Capital Mkts | Outperform |
2024-02-22 | 開始されました | Leerink Partners | Outperform |
2022-01-04 | ダウングレード | Barclays | Overweight → Equal Weight |
2021-08-27 | ダウングレード | Goldman | Neutral → Sell |
2021-06-25 | 再開されました | Goldman | Neutral |
2020-10-08 | 開始されました | Truist | Buy |
2020-04-22 | 開始されました | Goldman | Buy |
2020-02-27 | 開始されました | Barclays | Overweight |
2019-06-10 | 開始されました | Citigroup | Buy |
2019-06-10 | 開始されました | Cowen | Outperform |
2019-06-10 | 開始されました | Robert W. Baird | Outperform |
すべてを表示
Applied Therapeutics Inc (APLT) 最新ニュース
How Applied Therapeutics Inc. stock reacts to Fed policy changesTop Analyst Picks - Newser
Applied Therapeutics Inc. Stock Analysis and ForecastExplosive portfolio gains - jammulinksnews.com
What drives Applied Therapeutics Inc. stock priceConsistently superior profits - jammulinksnews.com
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics LawsuitAPLT - ACCESS Newswire
Is Applied Therapeutics Inc. a good long term investmentExplosive earnings growth - printweek.in
What analysts say about Applied Therapeutics Inc. stockExplosive trading opportunities - jammulinksnews.com
What makes Applied Therapeutics Inc. stock price move sharplyReal Time Stock Signal - Newser
How Applied Therapeutics Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser
Why Applied Therapeutics Inc. stock attracts strong analyst attentionFree Investing Community - Newser
Why Did Rapport Therapeutics Plunge 15.68%? Regulatory Setbacks, Financial Strain - AInvest
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. LawsuitAPLT - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit – APLT - ACCESS Newswire
Applied Therapeutics Requests to Dismiss Class Action Filed by Investors - TradingView
Bronstein, Gewirtz & Grossman, LLC Is Investigating Applied Therapeutics, Inc. (APLT) And Encourages Stockholders to Connect - ACCESS Newswire
Applied Therapeutics Plummets 15% Amid Technical Mystery: What's Behind the Drop? - AInvest
Applied Therapeutics Plummets 12.5%: What’s Behind the Unexplained Sell-Off? - AInvest
Applied Therapeutics promotes two executives to leadership roles By Investing.com - Investing.com South Africa
Applied Therapeutics Announces New Chief Medical Officer - TipRanks
APLT Announces Key Executive Promotions | APLT Stock News - GuruFocus
Applied Therapeutics Promotes Evan Bailey to Chief Medical Officer - MarketScreener
Applied Therapeutics Announces Key Leadership Appointments | APLT Stock News - GuruFocus
Applied Therapeutics promotes two executives to leadership roles - Investing.com
Applied Therapeutics Announces Key Leadership Appointments - GlobeNewswire
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New Investment in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World
California State Teachers Retirement System Purchases 64,316 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World
Applied Therapeutics holds annual stockholders meeting By Investing.com - Investing.com Canada
Applied Therapeutics Elects New Director at Annual Meeting - TipRanks
Applied Therapeutics holds annual stockholders meeting - Investing.com
Two Sigma Investments LP Buys New Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World
Analysts Set Applied Therapeutics, Inc. (NASDAQ:APLT) Target Price at $6.10 - Defense World
Brokerages Set Applied Therapeutics, Inc. (NASDAQ:APLT) Target Price at $6.10 - MarketBeat
Wellington Management Group LLP Boosts Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World
Applied Therapeutics, Inc. (NASDAQ:APLT) Shares Acquired by Millennium Management LLC - MarketBeat
Shareholder Rights Advocates at Levi & Korsinsky Investigate Applied Therapeutics, Inc. (APLT) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Applied Therapeutics, Inc. (NASDAQ:APLT) Short Interest Update - MarketBeat
Millennium Management LLC Boosts Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World
Applied Therapeutics Inc (APLT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):